NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical Study
Status:
Withdrawn
Trial end date:
2018-09-20
Target enrollment:
Participant gender:
Summary
Healthy adult men who abuse opioids and are physically dependent on them will be invited to
participate in a study to examine the ability of NT-814, a neurokinin (NK) antagonist at the
1 and 3 receptor subtypes, to alter the abuse liability of oxycodone.